icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
SAFETY AND EFFICACY OF THE ALL-ORAL REGIMEN OF MK-5172 / MK-8742 ± RIBAVIRIN IN TREATMENT-NAIVE, NONCIRRHOTIC PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: THE C-WORTHy STUDY
 
 
  Reported by Jules Levin
 
Presented at the 49th Annual Meeting of the European Association for the Study of the Liver
April 9-13, 2014, London, United Kingdom
 
Christophe Hezode, Lawrence Serfaty, John M. Vierling, Marcelo Kugelmas, Brian Pearlman, William Sievert, Wayne Ghesquiere, Eli Zuckerman, Fredrik Sund, Anita Howe, Melissa Shaughnessy, Peggy Hwang, Janice Wahl, Michael N. Robertson, Barbara Haber

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif